Meina Liang

Person

Fremont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-B7-H1 antibodies for treating tumors
- Patent number 11,827,706
- Issue date Nov 28, 2023
- MEDIMMUNE LIMITED
- Rajesh Narwal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PAD4 autoantibodies as clinical response biomarkers for the tr...
- Patent number 11,613,580
- Issue date Mar 28, 2023
- MedImmune Limited
- Rachel Patricia Moate
- G01 - MEASURING TESTING
Information Patent Grant
CCL20 as a predictor of clinical response to IL23-antagonists
- Patent number 11,220,541
- Issue date Jan 11, 2022
- Amgen Inc.
- Robert W. Georgantas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prediction of clinical response to IL23-antagonists using IL23 path...
- Patent number 11,016,099
- Issue date May 25, 2021
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Grant
Anti-B7-H1 antibodies for treating tumors
- Patent number 10,829,557
- Issue date Nov 10, 2020
- MedImmune Limited
- Rajesh Narwal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using antibodies to determine periostin levels in a sample
- Patent number 10,775,388
- Issue date Sep 15, 2020
- MedImmune, LLC
- Partha S. Chowdhury
- G01 - MEASURING TESTING
Information Patent Grant
Anti-B7-H1 antibodies for treating tumors
- Patent number 10,336,823
- Issue date Jul 2, 2019
- MedImmune Limited
- Rajesh Narwal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies which bind human periostin
- Patent number 9,862,762
- Issue date Jan 9, 2018
- MedImmune, LLC
- Partha Chowdhury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding antibodies to CCR2
- Patent number 9,238,691
- Issue date Jan 19, 2016
- Pfizer Inc.
- Ronald P. Gladue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to GPNMB and uses thereof
- Patent number 8,846,873
- Issue date Sep 30, 2014
- Celldex Therapeutics, Inc.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to CCR2
- Patent number 8,710,191
- Issue date Apr 29, 2014
- Pfizer Inc.
- Ronald P. Gladue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor and uses thereof
- Patent number 8,101,178
- Issue date Jan 24, 2012
- Amgen Fremont Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Patent number 7,687,606
- Issue date Mar 30, 2010
- Astrazeneca AB
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Patent number 7,482,434
- Issue date Jan 27, 2009
- Astrazeneca AB
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor
- Patent number 7,285,269
- Issue date Oct 23, 2007
- Amgen Fremont, Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 7,268,140
- Issue date Sep 11, 2007
- Schering AG
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinoline CCR5 receptor antagonists
- Patent number 7,220,856
- Issue date May 22, 2007
- Schering Aktiengesellschaft
- Laura Dunning
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Patent number 7,202,343
- Issue date Apr 10, 2007
- Abgenix, Inc.
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,977,258
- Issue date Dec 20, 2005
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,972,290
- Issue date Dec 6, 2005
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,573,266
- Issue date Jun 3, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,555,537
- Issue date Apr 29, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,541,476
- Issue date Apr 1, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,534,509
- Issue date Mar 18, 2003
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives and their use as anti-inflammatory agents
- Patent number 6,207,665
- Issue date Mar 27, 2001
- Schering Aktiengesellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS
- Publication number 20240150469
- Publication date May 9, 2024
- MEDIMMUNE LIMITED
- Rajest Narwal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TR...
- Publication number 20230303707
- Publication date Sep 28, 2023
- MEDIMMUNE LIMITED
- Rachel Patricia MOATE
- G01 - MEASURING TESTING
Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20220373539
- Publication date Nov 24, 2022
- Amgen Inc.
- Robert W. Georgantas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20220144935
- Publication date May 12, 2022
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS
- Publication number 20210171639
- Publication date Jun 10, 2021
- MEDIMMUNE LIMITED
- Rajesh Narwal
- G01 - MEASURING TESTING
Information Patent Application
ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TR...
- Publication number 20200317793
- Publication date Oct 8, 2020
- MEDIMMUNE LIMITED
- Rachel Patricia MOATE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20200262907
- Publication date Aug 20, 2020
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS
- Publication number 20190338033
- Publication date Nov 7, 2019
- MEDIMMUNE LIMITED
- Rajesh Narwal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20180252728
- Publication date Sep 6, 2018
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
- Publication number 20180196065
- Publication date Jul 12, 2018
- Medimmune, LLC
- Partha Chowdhury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
- Publication number 20180179272
- Publication date Jun 28, 2018
- Medimmune, LLC
- Partha Chowdhury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-...
- Publication number 20160363591
- Publication date Dec 15, 2016
- Medimmune, LLC
- Katie Streicher
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
- Publication number 20160311894
- Publication date Oct 27, 2016
- Medimmune, LLC
- Partha Chowdhury
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Directed To GPNMB And Uses Thereof
- Publication number 20160311919
- Publication date Oct 27, 2016
- CELLDEX THERAPEUTICS, INC.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-B7-H1 Antibodies for Treating Tumors
- Publication number 20160222120
- Publication date Aug 4, 2016
- Medlmmune Limited
- Rajesh Narwal
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Directed to GPNMB and Uses Thereof
- Publication number 20150044212
- Publication date Feb 12, 2015
- CELLDEX THERAPEUTICS, INC.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CCR2
- Publication number 20140342450
- Publication date Nov 20, 2014
- AMGEN FREMONT INC.
- Ronald P. Gladue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed To GPNMB And Uses Thereof
- Publication number 20130022597
- Publication date Jan 24, 2013
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CCR2
- Publication number 20110274696
- Publication date Nov 10, 2011
- Amgen Fremont Inc.
- Ronald P. Gladue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF
- Publication number 20080187531
- Publication date Aug 7, 2008
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Publication number 20070128112
- Publication date Jun 7, 2007
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Publication number 20070116708
- Publication date May 24, 2007
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20060135487
- Publication date Jun 22, 2006
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...
- Publication number 20050058639
- Publication date Mar 17, 2005
- Jean M. Gudas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to phospholipase A2 and uses thereof
- Publication number 20050058649
- Publication date Mar 17, 2005
- Gregory M. Landes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to tumor necrosis factor and uses thereof
- Publication number 20050049402
- Publication date Mar 3, 2005
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted quinoline CCR5 receptor antagonists
- Publication number 20040072818
- Publication date Apr 15, 2004
- SCHERING AKTIENGESELLSCHAFT
- Laura Dunning
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20030158205
- Publication date Aug 21, 2003
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20030139425
- Publication date Jul 24, 2003
- SCHERING AKTIENGESELLSCHAFT
- John G. Bauman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperazine derivatives and their use as anti-inflammatory agents
- Publication number 20020177598
- Publication date Nov 28, 2002
- Schering Aktiengschellschaft
- John G. Bauman
- C07 - ORGANIC CHEMISTRY

Meina Liang

Person

Patents Grantslast 30 patents

Anti-B7-H1 antibodies for treating tumors

Anti-PAD4 autoantibodies as clinical response biomarkers for the tr...

CCL20 as a predictor of clinical response to IL23-antagonists

Prediction of clinical response to IL23-antagonists using IL23 path...

Anti-B7-H1 antibodies for treating tumors

Methods of using antibodies to determine periostin levels in a sample

Anti-B7-H1 antibodies for treating tumors

Monoclonal antibodies which bind human periostin

Nucleic acids encoding antibodies to CCR2

Antibodies directed to GPNMB and uses thereof

Antibodies to CCR2

Antibodies directed to tumor necrosis factor and uses thereof

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Antibodies directed to tumor necrosis factor

Piperazine derivatives and their use as anti-inflammatory agents

Substituted quinoline CCR5 receptor antagonists

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Patents Applicationslast 30 patents

ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS

ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TR...

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS

ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TR...

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-...

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

Antibodies Directed To GPNMB And Uses Thereof

Anti-B7-H1 Antibodies for Treating Tumors

Antibodies Directed to GPNMB and Uses Thereof

ANTIBODIES TO CCR2

Antibodies Directed To GPNMB And Uses Thereof

ANTIBODIES TO CCR2

ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Piperazine derivatives and their use as anti-inflammatory agents

Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1)...

Antibodies directed to phospholipase A2 and uses thereof

Antibodies directed to tumor necrosis factor and uses thereof

Substituted quinoline CCR5 receptor antagonists

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents

Piperazine derivatives and their use as anti-inflammatory agents